Please login to the form below

Not currently logged in

Indigo Medical joins imc group

The addition of Indigo Medical boosts imc group’s geographic footprint and capabilities

Independent global healthcare communications group imc group has announced the addition of Indigo Medical to its roster.

Indigo Medical provides material review, medical signatory approval services and medical communications for global pharma and biopharma companies. The company has offices in the UK and was founded in 2014 by Tina Patel and Rak Patel, employing physicians, pharmacists and PhDs.

The addition of Indigo Medical bolsters imc group’s geographic footprint and capabilities. With the addition of Indigo, imc group will now offer services for clients across seven core divisions, including medical & scientific content, publications, digital & creative, insights & consulting, patient engagement, meetings & events and medical compliance & material review.

“Our partnership will ensure that more clients can benefit from our many years of experience in providing sector-leading compliance services, simplifying the burden of copy review and approval, and enabling the faster deployment of healthcare solutions,” said Rak Patel, co-founder and director of compliance and approval services at Indigo Medical.

"We are delighted to have found, in imc group, an organisation that not only shares this philosophy but enables us to expand our geographic footprint, providing a best-in- class service to our clients," added Tina Patel, co-founder and director of medical communication services at Indigo Medical.

Article by
Lucy Parsons

15th April 2021

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....